The Alliance for Regenerative Medicine is organizing a hybrid event this year, so you may attend in Carlsbad, CA or virtually.
This meeting features a mix of commercialization topics related to the cell and gene therapy sector, including international regulation harmonization, manufacturing and CMC challenges, among others. Over 80 presentations by leading public and private companies will highlight recent technical and clinical achievements in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine technologies.
We are happy to help sponsor this meeting to promote informative and productive discussions among our colleagues and partners.
Visit the meeting website for more information.